ANTIPSYCHOTIC-INDUCED WEIGHT GAIN (AIWG)

Clinical trials for ANTIPSYCHOTIC-INDUCED WEIGHT GAIN (AIWG) explained in plain language.

Never miss a new study

Get alerted when new ANTIPSYCHOTIC-INDUCED WEIGHT GAIN (AIWG) trials appear

Sign up with your email to follow new studies for ANTIPSYCHOTIC-INDUCED WEIGHT GAIN (AIWG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for fighting Medication-Related weight gain

Disease control Not yet recruiting

This study aims to find the best way to manage weight gain caused by antipsychotic medications used for schizophrenia. Researchers will compare three approaches over 26 weeks: adding the drug dapagliflozin, adding the drug metformin, or using lifestyle changes alone. The goal is …

Matched conditions: ANTIPSYCHOTIC-INDUCED WEIGHT GAIN (AIWG)

Phase: PHASE4 • Sponsor: Sultan Qaboos University • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

ANTIPSYCHOTIC-INDUCED WEIGHT GAIN (AIWG)

Get alerted when new ANTIPSYCHOTIC-INDUCED WEIGHT GAIN (AIWG) trials appear

New hope for fighting Medication-Related weight gain